Nolan Priedigkeit, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor alpha | 6 | 2022 | 580 | 0.700 |
Why?
|
Breast Neoplasms | 16 | 2022 | 21029 | 0.610 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2021 | 8512 | 0.470 |
Why?
|
Estrogens | 1 | 2021 | 1520 | 0.450 |
Why?
|
Hirschsprung Disease | 1 | 2015 | 163 | 0.430 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2554 | 0.370 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2005 | 0.350 |
Why?
|
Bone Neoplasms | 2 | 2022 | 2531 | 0.330 |
Why?
|
Evolution, Molecular | 2 | 2015 | 1885 | 0.330 |
Why?
|
Calcinosis | 1 | 2017 | 1476 | 0.320 |
Why?
|
Mutation | 8 | 2022 | 29957 | 0.290 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1741 | 0.260 |
Why?
|
Brain Neoplasms | 3 | 2020 | 8985 | 0.210 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2021 | 46 | 0.190 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2022 | 146 | 0.180 |
Why?
|
Gene Expression Profiling | 6 | 2021 | 9406 | 0.180 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2013 | 0.180 |
Why?
|
Cadherins | 2 | 2021 | 898 | 0.160 |
Why?
|
ADAM Proteins | 1 | 2020 | 240 | 0.160 |
Why?
|
Biomimetic Materials | 1 | 2020 | 173 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2018 | 53 | 0.160 |
Why?
|
Receptors, Angiotensin | 1 | 2017 | 141 | 0.150 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2017 | 148 | 0.140 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2022 | 938 | 0.140 |
Why?
|
Genes, erbB-2 | 1 | 2017 | 162 | 0.140 |
Why?
|
Allyl Compounds | 1 | 2016 | 22 | 0.140 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2017 | 159 | 0.140 |
Why?
|
Retinal Dehydrogenase | 1 | 2016 | 78 | 0.130 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 489 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2021 | 718 | 0.130 |
Why?
|
Mutant Chimeric Proteins | 1 | 2015 | 20 | 0.130 |
Why?
|
Melanoma | 1 | 2015 | 5697 | 0.130 |
Why?
|
Gene Amplification | 2 | 2018 | 1085 | 0.130 |
Why?
|
Computational Biology | 2 | 2021 | 3505 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 130 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 346 | 0.130 |
Why?
|
Sulfides | 1 | 2016 | 171 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 556 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1060 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 5251 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1096 | 0.110 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2022 | 1854 | 0.110 |
Why?
|
Gene Fusion | 1 | 2015 | 354 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1745 | 0.100 |
Why?
|
Aromatase | 1 | 2012 | 147 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 854 | 0.100 |
Why?
|
Chromosomes | 1 | 2015 | 575 | 0.100 |
Why?
|
Isoenzymes | 1 | 2016 | 1690 | 0.100 |
Why?
|
Genome, Human | 2 | 2015 | 4418 | 0.090 |
Why?
|
Recurrence | 2 | 2021 | 8483 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2873 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3800 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 2982 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1529 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2380 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3734 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2021 | 10442 | 0.080 |
Why?
|
NF-kappa B | 1 | 2017 | 2486 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3583 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2012 | 511 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4354 | 0.080 |
Why?
|
Mutagenesis | 1 | 2012 | 1234 | 0.080 |
Why?
|
Female | 20 | 2022 | 391246 | 0.080 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4878 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1347 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4408 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 503 | 0.070 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2015 | 1596 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1512 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1388 | 0.070 |
Why?
|
Oncogenes | 1 | 2012 | 1220 | 0.070 |
Why?
|
Humans | 23 | 2022 | 760613 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 12762 | 0.060 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4902 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9278 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3612 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2829 | 0.050 |
Why?
|
Prognosis | 5 | 2022 | 29661 | 0.050 |
Why?
|
RecQ Helicases | 1 | 2022 | 53 | 0.050 |
Why?
|
Cisplatin | 2 | 2022 | 1643 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1287 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2016 | 435 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3448 | 0.050 |
Why?
|
Software | 1 | 2015 | 4419 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6130 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2907 | 0.050 |
Why?
|
Mice, Nude | 2 | 2017 | 3607 | 0.040 |
Why?
|
Antigens, CD | 2 | 2021 | 4000 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 704 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4496 | 0.040 |
Why?
|
Lysine | 1 | 2022 | 1001 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2022 | 1526 | 0.040 |
Why?
|
Acrylates | 1 | 2016 | 79 | 0.030 |
Why?
|
Tamoxifen | 1 | 2021 | 963 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 729 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2022 | 1313 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 730 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 981 | 0.030 |
Why?
|
Platinum | 1 | 2016 | 223 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13982 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 224 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2022 | 949 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 41337 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2210 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12810 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
Physical Chromosome Mapping | 1 | 2013 | 182 | 0.030 |
Why?
|
Mice | 5 | 2019 | 81209 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 209 | 0.030 |
Why?
|
Eye Proteins | 1 | 2016 | 633 | 0.030 |
Why?
|
Consanguinity | 1 | 2013 | 456 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2698 | 0.020 |
Why?
|
CA-125 Antigen | 1 | 2014 | 279 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 717 | 0.020 |
Why?
|
Animals | 6 | 2020 | 167960 | 0.020 |
Why?
|
Nuclear Export Signals | 1 | 2010 | 9 | 0.020 |
Why?
|
Triazoles | 1 | 2016 | 904 | 0.020 |
Why?
|
Apoptosis | 2 | 2017 | 9497 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13627 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2010 | 77 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2013 | 1174 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1091 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13451 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6831 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1167 | 0.020 |
Why?
|
Gene Targeting | 1 | 2013 | 839 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16548 | 0.020 |
Why?
|
Half-Life | 1 | 2010 | 652 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17624 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2803 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 566 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7233 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16932 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3442 | 0.020 |
Why?
|
Adult | 3 | 2019 | 220007 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2013 | 2381 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2013 | 4169 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3618 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2640 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39262 | 0.020 |
Why?
|
Middle Aged | 2 | 2019 | 220359 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5797 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 4578 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5206 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3617 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2716 | 0.010 |
Why?
|
Signal Transduction | 2 | 2018 | 23374 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14494 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22052 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3959 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12957 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6596 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14374 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12102 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15620 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18137 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 58748 | 0.000 |
Why?
|
Neoplasms | 1 | 2015 | 22075 | 0.000 |
Why?
|
Male | 1 | 2013 | 359718 | 0.000 |
Why?
|